RxDoctor Payments Data

Chelsea Plakosh

Family · Aliquippa, PANPI 1962049254

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,568 and has fallen 93.4% since, to $104 in 2025.

$2,180in general payments, 2019–2025

Across 137 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$452
  • GSK$433
  • Pfizer$311
  • Sanofi-aventis U.S. LLC$222
  • Novo Nordisk$213
  • Lilly USA, LLC$129
  • plus $420 from 13 others

What the payments were for

  • Food & beverage$2,180100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,180 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Other family in Aliquippa

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →